Flow Cytometric immunophenotyping of peripheral T cell neoplasms Using CD3 gating

Acta Haematologica

Volumn 121, Issue 1, 2009, Pages 11-18

  Hara, Satoshi ^a   Yokote, Taiji ^a   Akioka, Toshikazu ^a   Miyoshi, Takuji ^a   Ikemoto, Toshiyuki ^a   Tanaka, Hidema ^a   Takubo, Takayuki ^a   Tsuji, Motomu ^a   Hanafusa, Toshiaki ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

CD3 gating; Flow cytometric immunophenotyping; Fluorescence activated cell sorting; Peripheral T cell neoplasms

Indexed keywords

CD3 ANTIGEN;

ADULT; ARTICLE; CD3+ T LYMPHOCYTE; CELL POPULATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; MYCOSIS FUNGOIDES; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; T CELL LEUKEMIA;

ANTIGENS, CD3; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; T-LYMPHOCYTES;

EID: 61849132796     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000209205     Document Type: Article

References (21)

1. Gisselbrecht C, Gaulard P, Lepage E, Coiffer B, Briere J, Haioun C, Cazals-Hatem D, Bosly A, Xerri L, Tilly H, Berger F, Bouhabdallah R, Diebold J: Prognostic significance of T cell phenotype in aggressive non-Hodgkin's lymphomas. Blood 1998; 92: 76-82.
2. Escalon MP, Liu NS, Yang Y, Hess M, Walker PL, Smith TL: Prognostic factors and treatment of patients with T cell non-Hodgkin lymphoma. Cancer 2005; 103: 2091-2098.
3. Corradini P, Tarella C, Zallio F, Dodero A, Zanni M, Valagussa P, Gianni AM, Rambaldi A, Barbui T, Cortelazzo S: Long-term follow- up of patients with peripheral T cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation. Leukemia 2006; 20: 1533-1538.
4. Kim SW, Tanimoto TE, Hirabayashi N, Goto S, Kami M, Yoshioka S, Uchida T, Kishi K, Tanaka Y, Kohno A, Kasai M, Higuchi M, Kasai M, Mori S, Fukuda T, Izutsu K, Sao M, Ishikawa T, Ichiohe T, Takeuchi K, Tajima K, Tanosaki R, Harada M, Taniguchi S, Tobinai K, Hotta T: Myeloablative allogeneic hematopoietic stem cell transplantation for non- Hodgkin lymphoma: a nationwide survey in Japan. Blood 2006; 108: 382-392.
5. Shah VO, Civin CI, Loken MR: Flow cytometric analysis of human bone marrow. IV. Differential quantitative expression of T-200 common leukocyte antigen during normal hemopoiesis. J Immunol 1988; 140: 1861- 1867.
6. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Duncan LM, Grange F, Harris NL, Kempf W, Kerl H, Kurrer M, Knobler R, Pimpinelli N, Sander C, Santucci M, Sterry W, Vermeer MH, Wechsler J, Whittaker S, Meijer CJ: WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768-3785.
7. Rudiger T, Weisenburger DD, Anderson JR, Armitage JO, Diebold J, MacLennan KA, Nathwani BN, Ullrich F, Muller-Hermelink HK: Peripheral T cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 2002; 13: 140- 149.
8. Matsushita K, Arima N, Hidaka S, Ohtsubo H, Fujiwara H, Fukumori J, Tanaka H: CD8- positive adult T cell leukemia cells with an integrated defective HTLV-I genome show a paracrine growth to IL-2. Am J Hematol 1994; 47: 123-128.
9. Lorand-Metze I, Pombo-de-Oliveira M: Adult T cell leukemia (ATL) with unusual immunophenotype and a high cellular proliferation rate. Leuk Lymphoma 1996; 22: 523-526.
10. Yamashita Y, Yatabe Y, Tsuzuki T, Nakayama A, Hasegawa Y, Kojima H, Nagasawa T, Mori N: Perforin and granzyme expression in cytotoxic T cell lymphomas. Mod Pathol 1998; 11: 313-323.
11. Geissinger E, Odenwald T, Lee SS, Bonzheim I, Roth S, Reimer P, Wilhelm P, Muller-Hermelink HK, Rudiger T: Nodal peripheral T cell lymphomas and, in particular, their lymphoepithelioid (Lennert's) variant are often derived from CD8+ cytotoxic T cells. Virchows Arch 2004; 445: 334-343.
12. Winberg CD, Sheibani K, Burke JS, Wu A, Rappaport H: T cell-rich lymphoproliferative disorders: morphologic and immunologic differential diagnoses. Cancer 1988; 62: 1539-1555.
13. Bagg A, Kallakury BV: Molecular pathology of leukemia and lymphoma. Am J Clin Pathol 1999; 112(suppl 1):S76-S92.
14. Medeiros LJ, Carr J: Overview of the role of molecular methods in the diagnosis of malignant lymphomas. Arch Pathol Lab Med 1999; 123: 1189-1207.
15. Ginaldi L, Matutes E, Farahat N, De Martinis M, Morilla R, Catovsky D: Differential expression of CD3 and CD7 in T cell malignancies: a quantitative study by flow cytometry. Br J Haematol 1996; 93: 921-927.
16. Meuer SC, Acute O, Hussey RE, Hodgdon JC, Fitzgerald KA, Schlossman SF, Reinherz EL: Evidence for the T3-associated 90K heterodimer as the T cell antigen receptor. Nature 1983; 303: 808-810.
17. Reinherz EL, Kung PC, Goldstein G, Levey RH, Schlossman SF: Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T cell lineage. Proc Natl Acad Sci USA 1980; 77: 1588-1592.
18. Weiss LM, Crabtree GS, Rouse RV, Warnke RA: Morphologic and immunologic characterization of 50 peripheral T cell lymphomas. Am J Pathol 1985; 118: 316-324.
19. Yokote T, Akioka T, Oka S, Hara S, Kobayashi K, Nakajima H, Yamano T, Ikemoto T, Shimizu A, Tsuji M, Hanafusa T: Flow cytometric immunophenotyping of adult T cell leukemia/lymphoma using CD3 gating. Am J Clin Pathol 2005; 124: 199-204.
20. Campana D, Coustan-Smith E: Detection of minimal residual disease in acute leukemia by flow cytometry. Cytometry 1999; 38: 139- 152.
21. Coustan-Smith E, Sancho J, Hancock ML, Boyett JM, Behm FG, Raimondi SC, Sandlund JT, Rivera GK, Rubnitz JE, Ribeiro RC, Pui CH, Campana D: Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood 2000; 96: 2691-2696.